1408282-72-3Relevant articles and documents
New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids
Behrends, Malte,Wagner, Stefan,Kopka, Klaus,Schober, Otmar,Sch?fers, Michael,Kumbhar, Sadhana,Waller, Mark,Haufe, Günter
, p. 3809 - 3818 (2015/08/03)
Abstract Matrix metalloproteinases (MMPs) are involved in a number of physiological as well as pathological processes such as atherosclerosis and tumorigenesis, where an up-regulation of MMPs is predominant. Fluorinated analogues of the hydroxamate-based